The prevalence of anemia in the patients who survived and died due to myocardial infarction (MI).
Introduction & Objective:Ischemia heart disease (IHD) is the most often met reason for losses in different communities. The most common reason of IHD is Atherosclerosis, and various etiologic factors such as high blood pressure, diabetes, smoking, and hyperlipidemia are involved in its development. Anemia is also considered another resulting reason of loss and morbidity in patients via IHD. Accordingly, the current paper aimed to determine the prevalence of anemia in patients who survived and died of myocardial infarction.Materials and Methods:The present research is of a case-control type, and the subjects were the patients with myocardial infarction admitted to Heart Ward of Hamadan Ekbatan Hospital within one year (2012-2013). The patients were divided into two categories of demised and survived after myocardial infarction, and in each 160-subject group, the prevalence of anemia with hemoglobin levels was investigated. Moreover, the demographic characteristics, ejection fraction, and patients' underlying medical conditions were also taken into account. The data obtained were analyzed by SPSS 15 software and chi-square test.Results:Of the 320 patients studied, 61 patients (19.1%) had anemia and 51 (83.6%) patients who were anemic had died. 31.7% of the deceased patients after MI were weak, while 6.3% of the survived patients after MI were anemic. Also, in all age and sex groups, anemia in the former patient group was higher than in the sustained group. The predominance of anemia was clearly greater in the women than in the men (P < 0.05).Conclusion:Based on the findings, there is a statistically clear variation in the prevalence of anemia in the former patient group after MI than in the group who survived after MI.
Department of Cardiology, Hamadan University of Medical Sciences, Hamadan, Iran.
F
F
Fariba
Department of Cardiology, Hamadan University of Medical Sciences, Hamadan, Iran.
M
M
Moradi
Department of Social Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.
M A
MA
Seifrabie
anemia; ischemic heart disease; myocardial infarction